Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $6.11MP/E –Yield –
Soligenix total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Soligenix's total debt was $162.49K at Sep 30, 2020.
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $162.49K | – |
| Q2 FY2020 | Jun 30, 2020 | $232.13K | – |
See a number that looks wrong?